West Health Policy Center, in partnership with Bentley University’s Center for Integration of Science and Industry, analyzed the financial practices of more than 1,300 public biopharmaceutical companies and their contributions to new drug development over the past two decades. Findings indicate that reducing drug prices should not slow innovation.
Webinar 3: Equitable Distribution of COVID-19 Vaccines
Event Summary and Key Takeaways: Ensuring equitable delivery of COVID-19 vaccines has had many complexities, tasking leaders to face both hard decisions and to be creative in producing solutions. The...
Read More
